With over 20 years in clinical research, Hanjing specializes in managing Phase I-III clinical trials across multiple therapeutic areas. Her expertise includes regulatory operations, IND submissions, and collaboration with the FDA, NIH, and industry partners. Hanjing is highly skilled in eCRF development, data management and biostatistics, ensuring high-quality data and compliant trial execution. She supports clinical programs from start-up through completion with precision and reliability.